The Personal Exoskeleton in use. [Image courtesy of Wandercraft] Wandercraft announced that it kicked off a landmark clinical ...

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

RapidAI announced that it received FDA 510(k) clearance for its Lumina 3D automated 3D imaging reconstruction solution.

Boston Scientific (NYSE: BSX) shares ticked up slightly before hours today on fourth-quarter results that beat the consensus ...

CVRx (Nasdaq:CVRX) shares took a hit today on fourth-quarter results that fell short of earnings per share expectations.

Newronika announced today that it received FDA investigational device exemption (IDE) for its deep brain stimulation (DBS) system.

Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...